Aveanna Healthcare (NASDAQ:AVAH) Trading Up 6.8% After Analyst Upgrade

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAHGet Free Report)’s stock price traded up 6.8% during trading on Monday after UBS Group raised their price target on the stock from $3.20 to $4.50. UBS Group currently has a sell rating on the stock. Aveanna Healthcare traded as high as $5.56 and last traded at $5.55. 280,641 shares traded hands during trading, an increase of 21% from the average session volume of 232,508 shares. The stock had previously closed at $5.19.

Separately, Truist Financial cut their target price on Aveanna Healthcare from $6.00 to $5.25 and set a “hold” rating for the company in a research note on Monday, January 6th.

Read Our Latest Stock Analysis on AVAH

Institutional Investors Weigh In On Aveanna Healthcare

Large investors have recently added to or reduced their stakes in the business. First Eagle Investment Management LLC acquired a new stake in Aveanna Healthcare in the fourth quarter valued at $1,992,000. Jacobs Levy Equity Management Inc. grew its stake in shares of Aveanna Healthcare by 297.6% in the 3rd quarter. Jacobs Levy Equity Management Inc. now owns 355,340 shares of the company’s stock valued at $1,848,000 after purchasing an additional 265,969 shares during the last quarter. Millennium Management LLC grew its position in Aveanna Healthcare by 105.0% in the 4th quarter. Millennium Management LLC now owns 400,374 shares of the company’s stock valued at $1,830,000 after buying an additional 205,023 shares during the last quarter. Connor Clark & Lunn Investment Management Ltd. acquired a new position in Aveanna Healthcare in the 3rd quarter valued at $817,000. Finally, Swiss National Bank purchased a new position in Aveanna Healthcare during the 4th quarter worth $434,000. 87.96% of the stock is owned by hedge funds and other institutional investors.

Aveanna Healthcare Trading Up 6.2 %

The company’s 50 day moving average price is $4.58 and its 200 day moving average price is $4.96. The company has a market cap of $1.06 billion, a price-to-earnings ratio of -16.21 and a beta of 2.25.

About Aveanna Healthcare

(Get Free Report)

Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities.

Further Reading

Receive News & Ratings for Aveanna Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aveanna Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.